Objectives: To report the outcomes of augmentation laryngoplasty using micronized alloderm for the management unilateral vocal fold paralysis in children. Indications for acute management and the observed longevity of micronized alloderm is discussed. Methods: Retrospective chart review of patients with unilateral vocal fold paralysis surgically managed at a tertiay care hospital between July 2002 and December 2003. Results: Eight children with unilateral vocal fold paralysis were identified. Age range at the time of surgical management was 3 weeks to 17 years. Follow-up ranged from 6 months to 14 months. Etiologies included cardiac surgery, idiopathic, and brainstem ependymoma. Five of 8 (62.5%) patients were managed in the acute setting; 4 of 8 (50%) of the augmentation laryngoplasty procedures were performed for significant aspiration, and the other 4 patients were managed for dysphonia. The clinically observed longevity of the micronized alloderm was 3 to 6 months. All patients managed for aspiration had significant objective improvement, and 3/4 (75%) were discharged home feeding orally. Three of 5 (60%) of the children managed in the acute setting had recovery of vocal fold function. No airway complications were observed. Conclusions: Augmentation laryngoplasty using micronized alloderm is a safe option for the acute management of aspiration associated with a unilateral vocal fold paralysis in children. The clinically observed longevity of the collagen in children is 3 to 6 months.
Read full abstract